Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Free Cash Flow (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Free Cash Flow for 9 consecutive years, with $212661.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 2327.64% year-over-year to $212661.0, compared with a TTM value of $1.2 million through Oct 2025, up 239.13%, and an annual FY2025 reading of $192774.0, up 151.29% over the prior year.
  • Free Cash Flow was $212661.0 for Q4 2025 at VitaNova Life Sciences, down from $263810.0 in the prior quarter.
  • Across five years, Free Cash Flow topped out at $479137.0 in Q2 2025 and bottomed at -$504001.0 in Q3 2024.
  • Average Free Cash Flow over 5 years is $14070.3, with a median of -$2285.0 recorded in 2023.
  • The sharpest move saw Free Cash Flow plummeted 8266.96% in 2024, then skyrocketed 2327.64% in 2025.
  • Year by year, Free Cash Flow stood at $19593.0 in 2021, then crashed by 72.92% to $5306.0 in 2022, then plummeted by 250.6% to -$7991.0 in 2023, then skyrocketed by 209.62% to $8760.0 in 2024, then surged by 2327.64% to $212661.0 in 2025.
  • Business Quant data shows Free Cash Flow for YJGJ at $212661.0 in Q4 2025, $263810.0 in Q3 2025, and $479137.0 in Q2 2025.